COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature.
Publication/Presentation Date
1-1-2020
Abstract
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a pandemic that has affected >188 countries, involved >24 million people, and caused >840,000 deaths. COVID-19, in its severe form, presents as acute respiratory distress syndrome (ARDS), shock, and multiorgan failure. Thrombotic microangiopathy of the lungs and kidneys has been observed in these patients. Elevated D-dimer levels have been observed in people with serious COVID-19 illness, and this could be helpful in guiding treatment with anticoagulation in these patients.
OBJECTIVE: To analyze the role of anticoagulation as a treatment modality for COVID-19.
METHODS: We present the unique case of a COVID-19 patient who developed sepsis, ARDS, acute kidney injury, and deep-vein thrombosis (DVT), who was deteriorating clinically. She was treated with anticoagulation.
RESULTS: There was rapid recovery after treatment with systemic anticoagulation.
CONCLUSIONS: Systemic anticoagulation could prove to be essential in the treatment of CO-VID-19. Further studies are required to assess its role in improving long-term morbidity and mortality in these patients.
Volume
10
Issue
6
First Page
462
Last Page
469
ISSN
1664-5502
Published In/Presented At
Mahajan, P., Dass, B., Radhakrishnan, N., & McCullough, P. A. (2020). COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature. Cardiorenal medicine, 10(6), 462–469. https://doi.org/10.1159/000511800
Disciplines
Medicine and Health Sciences
PubMedID
33091905
Department(s)
Department of Medicine, Cardiology Division, Fellows and Residents
Document Type
Article